Answers are grounded in this paper and cite their sources.
Randomized controlled trials (RCTs) are widely considered to be the gold standard for demonstrating efficacy in psychotherapy research.However, the clinical utility of "typical" RCTs for establishing routine care therapies has been a topic of long-standing debate in our field (Persons & Silberschatz, 1998)."Typical" refers to a study with a small to moderate sample size that targets a disorder according to a standardized diagnostic manual and is often waiting-list controlled (Carey & Stiles, 2016).Practitioners frequent ly express criticism about the external validity of such RCTs (Gyani et al., 2015;Safran et al., 2011).In qualitative investigations, therapists describe the "unrepresentativeness of RCTs" as a reason for why they do not regard clinical research as an important foundation for their everyday decision making (Gyani et al., 2015).A review suggested that the perceived "inflexibility" of manuals could also be related to the lack of interest of many practitioners and that therapists wonder whether the "standardized instructions" provided in them are useful for their heterogeneous clinical use cases (Speers et al., 2022).Similarly, from a methodological point of view, the inference to intra-individual variability from group-level research was challenged (Fisher et al., 2018).Furthermore, the substantial heterogeneity in treatment effects suggests that even if patients with the same diagnoses are treated with the same treatment by the same therapist, they respond differently (Herzog & Kaiser, 2022).Given the methodological challenges and the skepticism of therapists, we argue that the criticism regarding clinical science should be taken seriously.In this editorial, we present five ideas for improving psychotherapy research and for addressing the research practice gap.
No takes yet. Share an insight, caveat, or question.
Berg et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: